跳至主要内容
临床试验/TCTR20220701001
TCTR20220701001招募中4 期

EFFECTS OF PATIENT-CENTERED PHARMACEUTICAL CARE ON DRUG THERAPY AND HEALTH -RELATED QUALITY OF LIFE AND MEDICATION ADHERENCE IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER

/A0 个研究点目标入组 326 人开始时间: 2022年7月1日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
326

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • 1. Diagnosed as major depressive disorder according to the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-V), 2. Treated with antidepressants for at least 2 weeks, 3. Take medicine by himself, 4. Thai who can communicate and read Thai language, 5. Follow-up date is within 4 to 5 weeks.

排除标准

  • 1. Treated with other treatment i.e. CBT or ECT, 2. Diagnosed as other psychiatric disorders i.e. anxiety disorder schizophrenia, 3.Cognitive impairment (TMSE<=23), 4.Diagnosed as other chronic diease and are not stable, 5. Can not contact via a telephone, 6. Can not complete the questionnaire at the first time

研究者

发起方
/A

相似试验